Unlock instant, AI-driven research and patent intelligence for your innovation.

Borneol ester derivative of carboxylic acid nonsteraidal anti-inflammatory medicaments as well as preparation method and application of borneol ester derivative

A non-steroidal anti-inflammatory drug, borneol technology, applied in the field of medicine, can solve problems such as adverse drug reactions, liver first-pass effect, and inability to maintain a constant blood drug concentration, achieve good transdermal absorption characteristics, and avoid common side effects Effect

Inactive Publication Date: 2013-08-14
EAST CHINA UNIV OF SCI & TECH
View PDF2 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The object of the present invention is to provide a kind of bornyl ester derivative of carboxylic acid non-steroidal anti-inflammatory drug, and its preparation method and application, thus overcome the liver damage caused by oral administration of non-steroidal anti-inflammatory drug in the prior art. Defects such as first-pass effect, inability to maintain constant blood drug concentration, and adverse drug reactions

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Borneol ester derivative of carboxylic acid nonsteraidal anti-inflammatory medicaments as well as preparation method and application of borneol ester derivative
  • Borneol ester derivative of carboxylic acid nonsteraidal anti-inflammatory medicaments as well as preparation method and application of borneol ester derivative
  • Borneol ester derivative of carboxylic acid nonsteraidal anti-inflammatory medicaments as well as preparation method and application of borneol ester derivative

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Embodiment 1: the synthesis of naproxenbornyl ester

[0019] In a 250 mL round bottom flask, add 10.0 g of naproxen, 10.1 g of borneol, 17.9 g of DCC, 300 mg of 4-dimethylaminopyridine (DMAP), and react at 110°C-120°C for 24 hours. The reaction mixture was filtered with a funnel to remove the milky white solid in the mixture. Take the filtrate and add 200ml of pure water to mix it, put it in a separatory funnel, shake it for 3 minutes, let it stand for liquid separation, and keep the upper layer solution. Then get 200ml ethyl acetate to extract the above solution, get the upper organic phase and pour it into a 250ml Erlenmeyer flask, clean the organic solution with 20% sodium carbonate solution with 150ml concentration, and then place it in a separatory funnel for liquid separation , remove the lower aqueous phase. Then take out the remaining organic phase liquid, wash it once with about 150ml sodium chloride solution, wash the solution until neutral, and finally wash...

Embodiment 2

[0020] Embodiment 2: the synthesis of ketoprofen bornyl ester

[0021] In a 250mL round bottom flask, add 10g of ketoprofen, 9.1g of borneol, 16.2g of DCC, 300mg of DMAP, and react at 110°C-120°C for 24h. The reaction mixture was filtered with a funnel to remove the milky white solid in the mixture. Take the filtrate and add 200ml of pure water to mix it, put it in a separatory funnel, shake it for 3 minutes, let it stand for liquid separation, and keep the upper layer solution. Then get 200ml ethyl acetate to extract the above solution, get the upper organic phase and pour it into a 250ml Erlenmeyer flask, clean the organic solution with 20% sodium carbonate solution with 150ml concentration, and then place it in a separatory funnel for liquid separation , remove the lower aqueous phase. Then take out the remaining organic phase liquid, wash it once with about 150ml sodium chloride solution, wash the solution until neutral, and finally wash it again with pure water. The cl...

Embodiment 3

[0022] Embodiment 3: the synthesis of bornyl flufenamate

[0023] In a 250mL round bottom flask, add 10g of flufenamic acid, 8.2g of borneol, 14.7g of DCC, 300mg of DMAP, and react at 110°C-120°C for 24h. The reaction mixture was filtered with a funnel to remove the milky white solid in the mixture. Take the filtrate and add 200ml of pure water to mix it, put it in a separatory funnel, shake it for 3 minutes, let it stand for liquid separation, and keep the upper layer solution. Then get 200ml ethyl acetate to extract the above solution, get the upper organic phase and pour it into a 250ml Erlenmeyer flask, clean the organic solution with 20% sodium carbonate solution with 150ml concentration, and then place it in a separatory funnel for liquid separation , remove the lower aqueous phase. After taking out the remaining organic phase liquid, wash it once with about 150ml of sodium chloride solution until the solution is neutral, and finally wash it again with pure water. The...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a borneol ester derivative of carboxylic acid nonsteraidal anti-inflammatory medicaments as well as a preparation method and application of the borneol ester derivative. The borneol ester derivative is characterized by comprising a structural formula (shown in the specification), wherein R represents carboxylic substituents of the nonsteraidal anti-inflammatory medicaments. The nonsteraidal anti-inflammatory medicaments are a class of medicaments having antipyretic, anti-inflammatory and analgesic effects, but researches show that a series of side effects are brought after the large-dose medicaments are orally taken for a long time. The borneol ester derivative of the carboxylic acid nonsteraidal anti-inflammatory medicaments not only reserve activities of the nonsteraidal anti-inflammatory medicaments for inhibiting cyclooxygenases COX-1 and COX-2, but also show a good transdermal absorption property, and after carrying out analgesic experiments on animals, the class of novel compounds are proved to have a remarkable inhibition effect on the pain of the live animals after being transdermally delivered; and the class of compounds can be further used for preparing transdermal preparations, such as ointments, spray agents and pasters having anti-inflammatory and analgesic effects, so that a novel way for transdermal medicament delivery of the nonsteraidal anti-inflammatory medicaments is made.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a bornyl ester derivative of a carboxylic acid non-steroidal anti-inflammatory drug, a preparation method and application thereof. Background technique [0002] Nonsteroidal anti-inflammatory drugs (NSAIDs) are a class of drugs with antipyretic, anti-inflammatory, and analgesic effects, and are widely used in the treatment of inflammatory diseases, rheumatic diseases, pain, soft tissue and sports injuries, and fever. Treatment is the third largest class of drugs after antibiotics and vitamins. The mechanism of action of NSAIDs has been proven to block the synthesis of prostaglandin (PG) by inhibiting cyclooxygenase (COX) to achieve its anti-inflammatory effect. However, studies have shown that long-term high-dose oral use of NSAIDs will produce a series of side effects, the main adverse reactions are gastrointestinal ulcers, bleeding, liver and kidney damage, and cardiovascular damage. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C69/734C07C69/738C07C67/08C07C229/58C07C227/18A61K31/216A61K31/245A61P29/00
Inventor 任宇红林久丰倪克奉魏东芝
Owner EAST CHINA UNIV OF SCI & TECH